Publications 2018

Thème: Autoimmunité, Transplantation, Inflammation ; ATI

1 Berthod PE, Aho-Glélé S, Ornetti P, Chevallier O, Devilliers H, Ricolfi F, Bonnotte B, Loffroy R, Samson M. CT analysis of the aorta in giant-cell arteritis: a case-control study. Eur Radiol. 2018 Mar 29. doi: 10.1007/s00330-018-5311-8. [Epub ahead of print]. PMID: 29600479.

2 Beaussant Y, Daguindau E, Chauchet A, Rochigneux P, Tournigand C, Aubry R, Morin L. Hospital end-of-life care in haematological malignancies. BMJ Support Palliat Care. 2018 Feb 6. pii: bmjspcare-2017-001446. doi: 10.1136/bmjspcare-2017-001446. [Epub ahead of print]. PMID: 29434048.

3 Bouldoires B, Gil H, Soumagne T, Humbert S, Meaux Ruault N, Magy Bertrand N. [A predictive bacterial infection score according to eosinophil level: An observational study]. Rev Med Interne. 2018 Jan;39(1):10-16. doi: 10.1016/j.revmed.2017.10.425. PMID: 29223347.

4 Brenière C, Blanc C, Devilliers H, Samson M, Delpont B, Bielefeld P, Besancenot JF, Giroud M, Béjot Y. Associated arterial and venous cerebral manifestations in Behçet’s disease. Rev Neurol (Paris). 2018 Apr 25. pii: S0035-3787(16)30280-6. doi: 10.1016/j.neurol.2017.06.031. [Epub ahead of print]. PMID: 29704959.

5 Castelain F, Girardin P, Penven E, Pelletier F. Occupational contact dermatitis caused by polyurethane foam: 6 cases. Contact Dermatitis. 2018 Apr 10. doi: 10.1111/cod.12989. [Epub ahead of print]. PMID: 29635841.

6 Choux C, Cavalieri M, Barberet J, Samson M, Bonnotte B, Fauque P, Sagot P. [Immunosuppressive therapy and fertility preservation: Indications and methods]. Rev Med Interne. 2018 Feb 27. pii: S0248-8663(18)30046-8. doi: 10.1016/j.revmed.2018.02.010. [Epub ahead of print]. PMID: 29500075.

7 Charles P, Terrier B, Perrodeau É, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group. Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2). Ann Rheum Dis. 2018 Apr 25. pii: annrheumdis-2017-212878. doi: 10.1136/annrheumdis-2017-212878. [Epub ahead of print]. PMID: 29695500.

8 Coutier F, Meaux Ruault N, Crepin T, Bouiller K, Gil H, Humbert S, Bedgedjian I, Magy-Bertrand N. A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review. Ann Hematol. 2018 Mar;97(3):401-407. doi: 10.1007/s00277-017-3138-z. PMID: 28956126.

9 Courivaud C. [Incremental haemodialysis]. Nephrol Ther. 2018 Apr;14 Suppl 1:S89-S92. doi: 10.1016/j.nephro.2018.02.016. PMID: 29606268.

10 de Boysson H, Daumas A, Vautier M, Parienti JJ, Liozon E, Lambert M, Samson M, Ebbo M, Dumont A, Sultan A, Bonnotte B, Manrique A, Bienvenu B, Saadoun D, Aouba A. Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients. Autoimmun Rev. 2018 Apr;17(4):391-398. doi: 10.1016/j.autrev.2017.11.029. Epub 2018 Feb 7. PMID: 29427822.

11 Deshayes S, Georgin-Lavialle S, Hot A, Durel CA, Hachulla E, Rouanes N, Audia S, Le Gallou T, Quartier P, Urbanski G, Messer L, Klein S, de Boysson H, Bienvenu B, Grateau G, Aouba A. Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature Review. J Rheumatol. 2018 Mar;45(3):425-429. doi: 10.3899/jrheum.170684. PMID: 29335349.

12 Ducreux S, Dubois V, Amokrane K, Yakoub-Agha I, Labalette M, Michallet M, Rubio MT, Kennel A, Forcade E, Lafarge X, Bulabois CE, Masson D, Daguindau E, Devys A, Moalic V, Quelvennec E, Boudifa A, Picard C, Van Endert P, de Matteis M, Delbos F, Filloux M, Pedron B, Renac V, Hau F, Bonneau J, Parissiadis A, Fort M, Dormoy A, Maillard N, Jollet I, Chevallier P, Cesbron A, Bay JO, Quainon F, Garnier F, Socié G, Loiseau P, Porcher R, Peffault de Latour R; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC); Société Francophone d’Histocompatibilité et d’Immunogénétique (SFHI). HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation. Am J Hematol. 2018 May 4. doi: 10.1002/ajh.25133. [Epub ahead of print]. PMID: 29726580.

13 Gallian P, Barlet V, Mouna L, Gross S, Lecam S, Ricard C, Wind F, Pouchol E, Fabra C, Flan B, Visse C, Djoudi R, Couturier E, de Valk H, Tiberghien P, Roque-Afonso AM. Hepatitis A: an epidemiological survey in blood donors, France 2015 to 2017. Euro Surveill. 2018 May;23(21). doi: 10.2807/1560-7917.ES.2018.23.21.1800237. PMID: 29845926.

14 Galland J, Abbara S, Terrier B, Samson M, Tesnières A, Fournier JP, Braun M. [Simulation-based learning and internal medicine: Opportunities and current perspectives for a national harmonized program]. Rev Med Interne. 2018 Mar 13. pii: S0248-8663(17)31183-9. doi: 10.1016/j.revmed.2017.11.011. [Epub ahead of print]. PMID: 29548580.

15 Guillon B, Ecarnot F, Marcucci C, Ducloux D, Chatot M, Badoz M, Bonnet B, Chopard R, Frey P, Meneveau N, Schiele F. Incidence, Predictors, and Impact on Six-Month Mortality of Three Different Definitions of Contrast-Induced Acute Kidney Injury After Coronary Angiography. Am J Cardiol. 2018 Apr 1;121(7):818-824. doi: 10.1016/j.amjcard.2017.12.029. PMID: 29397881.

16 Guitton Z, Terriou L, Lega JC, Nove-Josserand R, Hie M, Amoura Z, Bussel JB, Hamidou M, Rosenthal E, Lioger B, Chauveau D, Chaminade A, Magy-Bertrand N, Michel M, Audia S, Godeau B, Mahevas M. Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists. Rheumatology (Oxford). 2018 May 10. doi: 10.1093/rheumatology/key119. [Epub ahead of print]. PMID: 29757439.

17 Hadjadj J, Canaud G, Mirault T, Samson M, Bruneval P, Régent A, Goulvestre C, Witko-Sarsat V, Costedoat-Chalumeau N, Guillevin L, Mouthon L, Terrier B; French Vasculitis Study Group. mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G. Rheumatology (Oxford). 2018 Feb 27. doi: 10.1093/rheumatology/key017. [Epub ahead of print]. PMID: 29506143.

18 Humbert P. Photoexposed skin, skin aging, bateman purpura and local vitamin c deficiency. J Eur Acad Dermatol Venereol. 2018 Apr 6. doi: 10.1111/jdv.14980. [Epub ahead of print]. PMID: 29633407.

19 Jacquin-Porretaz C, Castelain F, Daguindau E, Seilles E, Nardin C, Aubin F, Pelletier F. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases]. Ann Dermatol Venereol. 2018 Apr 16. pii: S0151-9638(18)30132-7. doi: 10.1016/j.annder.2018.02.012. [Epub ahead of print]. PMID: 29673745.

20 Mouloungui E, Zver T, Roux C, Amiot C. A protocol to isolate and qualify purified human preantral follicles in cases of acute leukemia, for future clinical applications. J Ovarian Res. 2018 Jan 5;11(1):4. doi: 10.1186/s13048-017-0376-6. PMID: 29304838.

21 Nardin C, Colas M, Curie V, Pelletier F, Puzenat E, Aubin F. Pregnancy After Tubal Sterilization in a Woman Treated with Biologics for Severe Psoriasis. Dermatol Ther (Heidelb). 2018 Mar 9. doi: 10.1007/s13555-018-0232-7. [Epub ahead of print]. PMID: 29524191.

22 Nakyai W, Tissot M, Humbert P, Grandmottet F, Viyoch J, Viennet C. Effects of Repeated UVA Irradiation on Human Skin Fibroblasts Embedded in 3D Tense Collagen Matrix. Photochem Photobiol. 2018 Feb 8. doi: 10.1111/php.12895. [Epub ahead of print]. PMID: 29421845.

23 Samson M, Bonnotte B. [Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?]. Rev Med Interne. 2018 Feb;39(2):75-77. doi: 10.1016/j.revmed.2017.11.003. PMID: 29217104.

24 Samson M, Espígol-Frigolé G, Terrades-García N, Prieto-González S, Corbera-Bellalta M, Alba-Rovira R, Hernández-Rodríguez J, Audia S, Bonnotte B, Cid MC. Biological treatments in giant cell arteritis & Takayasu arteritis. Eur J Intern Med. 2018 Apr;50:12-19. doi: 10.1016/j.ejim.2017.11.003. PMID: 29146018.

25 Samson M, Ghesquière T, Berthier S, Bonnotte B. Ustekinumab inhibits Th1 and Th17 polarisation in a patient with giant cell arteritis. Ann Rheum Dis. 2018 Feb;77(2):e6. doi: 10.1136/annrheumdis-2017-211622. PMID: 28501800.

26 Sevin M, Kubovcakova L, Pernet N, Causse S, Vitte F, Villeval JL, Lacout C, Cordonnier M, Rodrigues-Lima F, Chanteloup G, Mosca M, Chrétien ML, Bastie JN, Audia S, Sagot P, Ramla S, Martin L, Gleave M, Mezger V, Skoda R, Plo I, Garrido C, Girodon F, de Thonel A. HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis. Nat Commun. 2018 Apr 12;9(1):1431. doi: 10.1038/s41467-018-03627-9. PMID: 29650953.

27 Terrier B, Pagnoux C, Perrodeau É, Karras A, Khouatra C, Aumaître O, Cohen P, Decaux O, Desmurs-Clavel H, Maurier F, Gobert P, Quémeneur T, Blanchard-Delaunay C, Bonnotte B, Carron PL, Daugas E, Ducret M, Godmer P, Hamidou M, Lidove O, Limal N, Puéchal X, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides. Ann Rheum Dis. 2018 May 3. pii: annrheumdis-2017-212768. doi: 10.1136/annrheumdis-2017-212768. [Epub ahead of print]. PMID: 2972472.

28 Toussirot E, Béreau M, Vauchy C, Saas P. Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical Evidence. Front Physiol. 2018 Apr 24;9:440. doi: 10.3389/fphys.2018.00440. PMID: 29740348.

29 Wang Y, Tissot M, Rolin G, Muret P, Robin S, Berthon JY, He L, Humbert P, Viennet C. Development and validation of a simple method for the extraction of human skin melanocytes. Cytotechnology. 2018 Mar 21. doi: 10.1007/s10616-018-0207-7. [Epub ahead of print]. PMID: 29564589.

30 Wang Y, Viennet C, Jeudy A, Fanian F, He L, Humbert P. Assessment of the efficacy of a new complex antisensitive skin cream. J Cosmet Dermatol. 2018 Jan 22. doi: 10.1111/jocd.12486. [Epub ahead of print]. PMID: 29356277.

Thème: Thérapeutique ImmunoMoléculaire des Cancers ; TIM-C

1 Aarnink A, Richard C, Truntzer C, Vincent J, Bengrine L, Vienot A, Borg C, Ghiringhelli F. Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma. Oncotarget. 2018 May 22;9(39):25617-25629. doi: 10.18632/oncotarget.25424. eCollection 2018 May 22. PMID: 29876012.

2 Adotevi O, Godet Y, Galaine J, Lakkis Z, Idirene I, Certoux JM, Jary M, Loyon R, Laheurte C, Kim S, Dormoy A, Pouthier F, Barisien C, Fein F, Tiberghien P, Pivot X, Valmary-Degano S, Ferrand C, Morel P, Delabrousse E, Borg C. In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial. Oncoimmunology. 2018 Mar 19;7(5):e1424673. PMID: 29721386. PFB

3 André T, Vernerey D, Mineur L, Bennouna J, Desrame J, Faroux R, Fratte S, Hug de Larauze M, Paget-Bailly S, Chibaudel B, Bez J, Dauba J, Louvet C, Lepere C, Dupuis O, Becouarn Y, Mabro M, Egreteau J, Bouche O, Deplanque G, Ychou M, Galais MP, Ghiringhelli F, Dourthe LM, Bachet JB, Khalil A, Bonnetain F, de Gramont A, Taieb J; for PRODIGE investigators, GERCOR, Fédération Française de Cancérologie Digestive, and UNICANCER. 3 Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial. J Clin Oncol. 2018 Apr 5:JCO2017760355. doi: 10.1200/JCO.2017.76.0355. [Epub ahead of print]. PMID: 29620995.

4 Asgarova A, Asgarov K, Godet Y, Peixoto P, Nadaradjane A, Boyer-Guittaut M, Galaine J, Guenat D, Mougey V, Perrard J, Pallandre JR, Bouard A, Balland J, Tirole C, Adotevi O, Hendrick E, Herfs M, Cartron PF, Borg C, Hervouet E. PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma. Oncoimmunology. 2018 Feb 1;7(5):e1423170. doi: 10.1080/2162402X.2017.1423170. PMID: 29721376.

5 Auclin E, André T, Taieb J, Benetkiewicz M, de Gramont A, Vernerey D. Low-level postoperative carcinoembryonic antigen improves survival outcomes stratification in patients with stage II colon cancer treated with standard adjuvant treatments. Eur J Cancer. 2018 May 3. pii: S0959-8049(18)30782-2. doi: 10.1016/j.ejca.2018.03.032. [Epub ahead of print]. PMID: 29731226.

6 Bachet JB, Bouché O, Taieb J, Dubreuil O, Garcia ML, Meurisse A, Normand C, Gornet JM, Artru P, Louafi S, Bonnetain F, Thirot-Bidault A, Baumgaertner I, Coriat R, Tougeron D, Lecomte T, Mary F, Aparicio T, Marthey L, Taly V, Blons H, Vernerey D, Laurent-Puig P. RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study. Ann Oncol. 2018 Feb 9. doi: 10.1093/annonc/mdy061. [Epub ahead of print]. PMID: 29438522.

7 Baraquin A, Hervouet E, Richou C, Flori P, Peixoto P, Azizi A, Delabrousse E, Blagosklonov O, Umhang G, Bresson-Hadni S, Valot B, Grenouillet F; EchinoVista study group. Circulating cell-free DNA in patients with alveolar echinococcosis. Mol Biochem Parasitol. 2018 Apr 18;222:14-20. doi: 10.1016/j.molbiopara.2018.04.004. [Epub ahead of print]. PMID: 29679605.

8 Bascoul-Mollevi C, Savina M, Anota A, Barbieri A, Azria D, Bonnetain F, Gourgou S. Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD. Comput Methods Programs Biomed. 2018 May;158:153-159. doi: 10.1016/j.cmpb.2018.02.010. Epub 2018 Feb 17. PMID: 29544781.

9 Bellanger AP, Berceanu A, Rocchi S, Valot B, Fontan J, Chauchet A, Belin N, Scherer E, Deconinck E, Navellou JC, Millon L. Development of a quantitative PCR detecting Cunninghamella bertholletiae to help in diagnosing this rare and aggressive mucormycosis. Bone Marrow Transplant. 2018 Apr 30. doi: 10.1038/s41409-018-0194-5. [Epub ahead of print]. PMID: 29712993.

10 Brédart A, Anota A, Dick J, Kuboth V, Lareyre O, De Pauw A, Cano A, Stoppa-Lyonnet D, Schmutzler R, Dolbeault S, Kop JL. Patient-Centered Care in Breast Cancer Genetic Clinics. Int J Environ Res Public Health. 2018 Feb 12;15(2). pii: E319. doi: 10.3390/ijerph15020319. PMID: 29439543.

11 Brédart A, Anota A, Young T, Tomaszewski KA, Arraras JI, Moura De Albuquerque Melo H, Schmidt H, Friend E, Bergenmar M, Costantini A, Vassiliou V, Hureaux J, Marchal F, Tomaszewska IM, Chie WC, Ramage J, Beaudeau A, Conroy T, Bleiker E, Kulis D, Bonnetain F, Aaronson NK; EORTC Quality of Life Group. Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT-PATSAT7). Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12786. Epub 2017 Nov 2. PMID: 29094784.

12 Cadranel J, Cortot AB, Lena H, Mennecier B, Do P, Dansin E, Mazieres J, Chouaid C, Perol M, Barlesi F, Robinet G, Friard S, Thiberville L, Audigier-Valette C, Vergnenegre A, Westeel V, Slimane K, Buturuga A, Moro-Sibilot D, Besse B. Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients. ERJ Open Res. 2018 Feb 13;4(1). pii: 00058-2017. doi: 10.1183/23120541.00058-2017. eCollection 2018 Jan. PMID: 29450203.

13 Cesaro S, Tridello G, Blijlevens N, Ljungman P, Craddock C, Michallet M, Martin A, Snowden JA, Mohty M, Maertens J, Passweg J, Petersen E, Nihtinen A, Isaksson C, Milpied N, Rohlich PS, Deconinck E, Crawley C, Ledoux MP, Hoek J, Nagler A, Styczynski J. Incidence, Risk Factors and Long-Term Outcome of Acute Leukemia Patients with Early Candidemia after Allogeneic Stem Cell Transplantation. A Study by the Acute Leukemia and Infectious Diseases Working Parties of EBMT. Clin Infect Dis. 2018 Feb 22. doi: 10.1093/cid/ciy150. [Epub ahead of print]. PMID: 29481599.

14 Craddock C, Versluis J, Labopin M, Socie G, Huynh A, Deconinck E, Volin L, Milpied N, Bourhis JH, Rambaldi A, Chevallier P, Blaise D, Manz M, Vellenga E, Vekemans MC, Maertens J, Passweg J, Vyas P, Schmid C, Löwenberg B, Ossenkoppele G, Mohty M, Cornelissen JJ, Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and HOVON-SAKK. Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia. J Intern Med. 2018 Apr;283(4):371-379. doi: 10.1111/joim.12720. PMID: 29214689.

15 Decroocq J, Itzykson R, Vigouroux S, Michallet M, Yakoub-Agha I, Huynh A, Beckerich F, Suarez F, Chevallier P, Nguyen-Quoc S, Ledoux MP, Clement L, Hicheri Y, Guillerm G, Cornillon J, Contentin N, Carre M, Maillard N, Mercier M, Mohty M, Beguin Y, Bourhis JH, Charbonnier A, Dauriac C, Bay JO, Blaise D, Deconinck E, Jubert C, Raus N, Peffault de Latour R, Dhedin N. Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Am J Hematol. 2018 Mar;93(3):416-423. doi: 10.1002/ajh.25004. PMID: 29226497.

16 Dosset M, Vargas TR, Lagrange A, Boidot R, Végran F, Roussey A, Chalmin F, Dondaine L, Paul C, Marie-Joseph EL, Martin F, Ryffel B, Borg C, Adotévi O, Ghiringhelli F, Apetoh L. PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer. Oncoimmunology. 2018 Mar 15;7(6):e1433981. doi: 10.1080/2162402X.2018.1433981. eCollection 2018. PMID: 29872568.

17 Efficace F, Cottone F, Abel G, Niscola P, Gaidano G, Bonnetain F, Anota A, Caocci G, Cronin A, Fianchi L, Breccia M, Stauder R, Platzbecker U, Palumbo GA, Luppi M, Invernizzi R, Bergamaschi M, Borin L, Di Tucci AA, Zhang H, Sprangers M, Vignetti M, Mandelli F. Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes. Cancer. 2018 Mar 15;124(6):1251-1259. doi: 10.1002/cncr.31193. Epub 2017 Dec 12. PMID: 29231969.

18 Fiteni F, Paillard MJ, Orillard E, Lefebvre L, Nadjafizadeh S, Selmani Z, Benhamida S, Roland A, Baumann A, Vienot A, Houédé N, Pivot X. Enterocolitis in Patients with Cancer Treated with Docetaxel. Anticancer Res. 2018 Apr;38(4):2443-2446. PMID: 29599375.

19 Garban F, Guyard A, Labussière H, Bulabois CE, Marchand T, Mounier C, Caillot D, Bay JO, Coiteux V, Schmidt-Tanguy A, Le Niger C, Robin C, Ladaique P, Lapusan S, Deconinck E, Rolland C, Foote AM, François A, Jacquot C, Tardivel R, Tiberghien P, Bosson JL; Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process (EFFIPAP) Study Group. Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial. JAMA Oncol. 2018 Apr 1;4(4):468-475. doi: 10.1001/jamaoncol.2017.5123. PMID: 29392283.

20 Gillet N, Fouquereau E, Coillot H, Bonnetain F, Dupont S, Moret L, Anota A, Colombat P. Ethical leadership, professional caregivers’ well-being, and patients’ perceptions of quality of care in oncology. Eur J Oncol Nurs. 2018 Apr;33:1-7. doi: 10.1016/j.ejon.2018.01.002. Epub 2018 Jan 12. PMID: 29551170.

21 Gligorov J, Richard S, Pivot X. Emilia: use cunning to survive cancer. Chin Clin Oncol. 2018 Feb;7(1):5. doi: 10.21037/cco.2017.11.04. PMID: 29307196.

22 Grothey A, Sobrero AF, Shields AF, Yoshino T, Paul J, Taieb J, Souglakos J, Shi Q, Kerr R, Labianca R, Meyerhardt JA, Vernerey D, Yamanaka T, Boukovinas I, Meyers JP, Renfro LA, Niedzwiecki D, Watanabe T, Torri V, Saunders M, Sargent DJ, Andre T, Iveson T. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer. N Engl J Med. 2018 Mar 29;378(13):1177-1188. doi: 10.1056/NEJMoa1713709. PMID: 29590544.

23 Hervouet E, Peixoto P, Delage-Mourroux R, Boyer-Guittaut M, Cartron PF. Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma. Clin Epigenetics. 2018 Feb 9;10:17. doi: 10.1186/s13148-018-0450-y. PMID: 29449903.

24 Kroemer M, Spehner L, Mercier-Letondal P, Boullerot L, Kim S, Jary M, Galaine J, Picard E, Ferrand C, Nguyen T, Larosa F, Adotévi O, Godet Y, Borg C. SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts. Oncoimmunology. 2018 Jan 17;7(4):e1412030. doi: 10.1080/2162402X.2017.1412030. PMID: 29632725.

25 Kumar A, Tripathy MK, Pasquereau S, Al Moussawi F, Abbas W, Coquard L, Khan KA, Russo L, Algros MP, Valmary-Degano S, Adotevi O, Morot-Bizot S, Herbein G. The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells. EBioMedicine. 2018 Mar 28. pii: S2352-3964(18)30099-9. doi: 10.1016/j.ebiom.2018.03.015. [Epub ahead of print]. PMID: 29628341.

26 Lamy T, Damaj G, Soubeyran P, Gyan E, Cartron G, Bouabdallah K, Gressin R, Cornillon J, Banos A, Le Du K, Benchalal M, Moles MP, Le Gouill S, Fleury J, Godmer P, Maisonneuve H, Deconinck E, Houot R, Laribi K, Marolleau JP, Tournilhac O, Branger B, Devillers A, Vuillez JP, Fest T, Colombat P, Costes V, Szablewski V, Béné MC, Delwail V; LYSA Group. R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma. Blood. 2018 Jan 11;131(2):174-181. doi: 10.1182/blood-2017-07-793984. PMID: 29061568.

27 Loubière S, Drezet A, Beau-Faller M, Moro-Sibilot D, Friard S, Wislez M, Blons H, Daniel C, Westeel V, Madroszyk A, Léna H, Merle P, Mazières J, Zalcman G, Lacave R, Antoine M, Morin F, Missy P, Barlesi F, Auquier P, Cadranel J; French Cooperative Thoracic Intergroup (IFCT). Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study. Eur Respir J. 2018 Mar 15;51(3). pii: 1701467. doi: 10.1183/13993003.01467-2017. PMID: 29545318.

28 Magne J, Jenvrin A, Chauchet A, Casasnovas O, Donzel A, Jego L, Aral B, Guy J, Nadal N, Vernerey D, Callier P, Garnache-Ottou F, Ferrand C. Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies. Exp Hematol Oncol. 2018 Feb 20;7:5. doi: 10.1186/s40164-018-0097-6. PMID: 29484276.

29 Mouillet G, Paillard MJ, Maurina T, Vernerey D, Nguyen Tan Hon T, Almotlak H, Stein U, Calcagno F, Berthod D, Robert E, Meurisse A, Thiery-Vuillemin A. Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial. Trials. 2018 Apr 12;19(1):221. doi: 10.1186/s13063-018-2613-8. PMID: 29650037.

30 Peffault de Latour R, Tabrizi R, Marcais A, Leblanc T, Lamy T, Mohty M, Tavitian S, Jubert C, Pasquet M, Galambrun C, Nguyen S, Cahn JY, Braun T, Deconinck E, Bay JO, Sicre de Fontbrune F, Barraco F, Socié G. Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia. Am J Hematol. 2018 May;93(5):635-642. doi: 10.1002/ajh.25050. PMID: 29377260.

31 Pivot X, Bondarenko I, Nowecki Z, Dvorkin M, Trishkina E, Ahn JH, Vinnyk Y, Im SA, Sarosiek T, Chatterjee S, Wojtukiewicz MZ, Moiseyenko V, Shparyk Y, Bello M 3rd, Semiglazov V, Song S, Lim J. Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. J Clin Oncol. 2018 Apr 1;36(10):968-974. doi: 10.1200/JCO.2017.74.0126. PMID: 29373094.

32 Pivot X, Cox DG, Gligorov J. Why the results of adjuvant pertuzumab in HER2-positive early breast cancer has been received as a mitigate success? Chin Clin Oncol. 2018 Feb;7(1):1. doi: 10.21037/cco.2017.10.07. PMID: 29156890.

33 Pourcelot C, Orillard E, Nallet G, Dirand C, Billion-Rey F, Barbier G, Chouk S, Limat S, Montcuquet P, Henriques J, Paget-Bailly S, Anota A, Chaigneau L, Nerich V. Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence. Breast Cancer Res Treat. 2018 May;169(1):153-162. doi: 10.1007/s10549-018-4676-3. Epub 2018 Jan 23. PMID: 29362956.

34 Salvatore D, Labopin M, Ruggeri A, Battipaglia G, Ghavamzadeh A, Ciceri F, Blaise D, Arcese W, Socié G, Bourhis JH, Van Lint M, Bruno B, Huynh A, Santarone S, Deconinck E, Mohty M, Nagler A. Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica. 2018 May 10. pii: haematol.2018.189258. doi: 10.3324/haematol.2018.189258. [Epub ahead of print]. PMID: 29748438.

35 Schillinger F, Sourdeau E, Boubaya M, Baseggio L, Clauser S, Cornet E, Debord C, Defour JP, Dubois F, Eveillard M, Galoisy AC, Geay MO, Mullier F, Nivaggioni V, Soenen V, Morel P, Garnache-Ottou F, Ronez E, Bardet V, Deconinck E. A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XNTM analyzers in routine laboratory practice. Scand J Clin Lab Invest. 2018 May;78(3):159-164. doi: 10.1080/00365513.2018.1423702. PMID: 29310473.

36 Seigeot A, Desmarets M, Rumpler A, Leroux F, Deconinck E, Monnet E, Bardiaux L. Factors related to the outcome of prophylactic platelet transfusions in patients with hematologic malignancies: an observational study. Transfusion. 2018 Mar 14. doi: 10.1111/trf.14592. [Epub ahead of print]. PMID: 29542122.

37 Shimoni A, Labopin M, Savani B, Hamladji RM, Beelen D, Mufti G, Socié G, Delage J, Blaise D, Chevallier P, Forcade E, Deconinck E, Mohty M, Nagler A. Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2018 Apr;24(4):751-757. doi: 10.1016/j.bbmt.2017.12.776. PMID: 29247780.

38 Tozatto-Maio K, Giannotti F, Labopin M, Ruggeri A, Volt F, Paviglianiti A, Kenzey C, Hayashi H, Cornelissen J, Michallet M, Karakasis D, Deconinck E, Rohrlich PS, de la Tour RP, Blaise D, Petersen E, D’Aveni M, Sengeloev H, Lamy T, Russell NH, Forcade E, Craddock CF, Nagler A, Gluckman E, Rocha V. Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2018 Mar 1. pii: S1083-8791(18)30092-2. doi: 10.1016/j.bbmt.2018.02.014. [Epub ahead of print]. PMID: 29477777.

39 Verine J, Colin D, Nheb M, Prapotnich D, Ploussard G, Cathelineau X, Desgrandchamps F, Mongiat-Artus P, Feugeas JP. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems. Am J Surg Pathol. 2018 Apr;42(4):423-441. doi: 10.1097/PAS.0000000000001025. PMID: 29356723.